Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Economics Of Precision Medicine: Will It Lower Drug Costs?

This article was originally published in Scrip

Executive Summary

While some have asserted tailoring treatments and cures to individuals will make therapies significantly more expensive, Francis Collins, director of the National Institutes of Health (NIH), said he thinks there's a "fair chance" precision medicine approaches will actually lead to a drop in research and development costs, thereby lowering the amounts patients pay for those products.

Advertisement
Advertisement
UsernamePublicRestriction

Register

SC064596

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Add a personalized Question to your Analyst

Cancel